Biomarin Pharmaceutical, Inc.
Lobbying group · Jul 2025 – Sep 2026
Biomarin Pharmaceutical, Inc. spent $1.5M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, medicare & medicaid, tariffs. It used 9 lobbyists, including people who worked for 4 members of Congress.
- Spent on lobbying
- $1.5M
- Lobbyists
- 9
- Bills lobbied
- 6
- Issues
- 7
Spending by quarter
- 2025 Q3$270K
- 2025 Q4$390K
- 2026 Q1$530K
- 2026 Q2$340K
Issues lobbied
- Health care
- Medicare & Medicaid
- Tariffs
- Pharmacy
- Budget & spending
- Taxes
- Media
Bills lobbied on
- H.R. 1262: Give Kids a Chance Act of 20252 reports
- S. 7522 reports
- S. 16372 reports
- S. 9322 reports
- H.R. 1509: Accelerating Kids’ Access to Care Act of 20252 reports
- H.R. 5371: Continuing Appropriations and Extensions Act, 20261 report
Lobbying firms hired
- Biomarin Pharmaceutical Inc.$1.5M
- Bgr Government Affairs$200K
- Lmh Strategic Solutions$60K
Lobbyists who worked in Congress
- Remy Mason
Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen…Elizabeth Warren (D-MA) - Remy Mason
Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen…Patty Murray (D-WA) - Daniel Farmer
Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for…Debbie Wasserman Schultz (D-FL) - James Williams
Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, WH Council of Economic Advisors…Frederica S. Wilson (D-FL)
Agencies contacted
- House Of Representatives · 25
- Senate · 23
- Health & Human Services, Dept of (Hhs) · 11
- Executive Office of the President (Eop) · 5
- Food & Drug Administration (Fda) · 5
- Commerce, Dept of (Doc) · 3
Related
Filings
- 2026 Q2 report$50K
- 2026 Q2 report$340K
- 2026 Q1 report$50K
- 2026 Q1 report$530K
- 2025 Q4 report$50K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Biomarin Pharmaceutical, Inc.: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cbiomarinpharmaceutical/biomarin-pharmaceutical-inc (accessed 2026-10-15).